Position in REPL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,605,931
+$1,039,281 QoQ
Shares Held
235,405
+14.9% QoQ
Ownership
0.250%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 199 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. REPL ranks #135 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in REPL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,605,931 | 235,405 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $1,566,650 | 204,791 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,033,636 | 209,222 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $843,474 | 201,307 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,918,959 | 206,562 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $1,844,473 | 189,177 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $2,113,411 | 174,518 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,782,368 | 162,625 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,622,034 | 180,226 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,329,707 | 162,755 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $1,421,069 | 168,573 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $2,864,743 | 167,431 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $3,906,438 | 168,236 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $3,061,729 | 173,371 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $4,557,876 | 167,569 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $2,531,125 | 146,562 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,833,546 | 104,894 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,852,110 | 109,076 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,966,961 | 109,482 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,731,888 | 92,169 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $3,009,592 | 78,334 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,654,918 | 87,018 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,357,695 | 88,013 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,458,362 | 63,352 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,229,775 | 49,488 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $338,231 | 33,925 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||